These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18546855)

  • 1. [Visualization of prostate cancer with 11C-choline positron emission tomography (PET): localization of primary and recurrent prostate cancer].
    Kanda T; Nakagomi K; Goto S; Torizuka T
    Hinyokika Kiyo; 2008 May; 54(5):325-32. PubMed ID: 18546855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.
    Yoshida S; Nakagomi K; Goto S; Futatsubashi M; Torizuka T
    Urol Int; 2005; 74(3):214-20. PubMed ID: 15812206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging.
    Giovacchini G; Picchio M; Briganti A; Cozzarini C; Scattoni V; Salonia A; Landoni C; Gianolli L; Di Muzio N; Rigatti P; Montorsi F; Messa C
    J Urol; 2010 Sep; 184(3):938-43. PubMed ID: 20643445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
    Picchio M; Messa C; Landoni C; Gianolli L; Sironi S; Brioschi M; Matarrese M; Matei DV; De Cobelli F; Del Maschio A; Rocco F; Rigatti P; Fazio F
    J Urol; 2003 Apr; 169(4):1337-40. PubMed ID: 12629355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    Eur Urol; 2003 Jul; 44(1):32-8; discussion 38-9. PubMed ID: 12814672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography.
    Breeuwsma AJ; Pruim J; van den Bergh AC; Leliveld AM; Nijman RJ; Dierckx RA; de Jong IJ
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):160-4. PubMed ID: 19783375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
    Castellucci P; Fuccio C; Nanni C; Santi I; Rizzello A; Lodi F; Franceschelli A; Martorana G; Manferrari F; Fanti S
    J Nucl Med; 2009 Sep; 50(9):1394-400. PubMed ID: 19690023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment.
    Mitchell CR; Lowe VJ; Rangel LJ; Hung JC; Kwon ED; Karnes RJ
    J Urol; 2013 Apr; 189(4):1308-13. PubMed ID: 23123372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study.
    Ceci F; Schiavina R; Castellucci P; Brunocilla E; Fuccio C; Colletti PM; Ferretti A; Chondrogiannis S; Rubello D; Romagnoli D; Malizia C; Martorana G; Fanti S
    Clin Nucl Med; 2013 Jul; 38(7):e279-82. PubMed ID: 23698461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [11C]choline PET for the intraprostatic tumor characterization and localization in recurrent prostate cancer after EBRT.
    Rybalov M; Breeuwsma AJ; Pruim J; Leliveld AM; Rosati S; Veltman NC; Dierckx RA; De Jong IJ
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):202-8. PubMed ID: 22402821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
    Karnes RJ; Murphy CR; Bergstralh EJ; DiMonte G; Cheville JC; Lowe VJ; Mynderse LA; Kwon ED
    J Urol; 2015 Jan; 193(1):111-6. PubMed ID: 25150640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
    Raj GV; Partin AW; Polascik TJ
    Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear medicine studies of the prostate, testes, and bladder.
    Jana S; Blaufox MD
    Semin Nucl Med; 2006 Jan; 36(1):51-72. PubMed ID: 16356796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml].
    Rioja Zuazu J; Rodríguez M; Rincón Mayans A; Sansi AS; Zudaire Bergera JJ; Martínez-Monge R; Richter JA; Berián Polo JM
    Actas Urol Esp; 2009 Sep; 33(8):844-52. PubMed ID: 19900376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
    Greco C; Cascini GL; Tamburrini O
    Prostate Cancer Prostatic Dis; 2008; 11(2):121-8. PubMed ID: 18180806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
    Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
    BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
    Wachter S; Tomek S; Kurtaran A; Wachter-Gerstner N; Djavan B; Becherer A; Mitterhauser M; Dobrozemsky G; Li S; Pötter R; Dudczak R; Kletter K
    J Clin Oncol; 2006 Jun; 24(16):2513-9. PubMed ID: 16636343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL.
    Telo S; Fanti S; Nanni C; Lambertini A; Picchio M; Gianolli L; Schiavina R; Bianchi L; Briganti A; Mapelli P; Castellucci P; Farolfi A
    Nucl Med Commun; 2020 Nov; 41(11):1178-1182. PubMed ID: 32804916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
    Schöder H; Herrmann K; Gönen M; Hricak H; Eberhard S; Scardino P; Scher HI; Larson SM
    Clin Cancer Res; 2005 Jul; 11(13):4761-9. PubMed ID: 16000572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.